Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study.

Abstract

To evaluate the safety and efficacy of an induction dose of pegylated interferon alpha 2a (IFN-alpha2a) on the 12-week hepatitis C virus (HCV) kinetics in human immunodeficiency virus (HIV) patients co-infected with HCV. One hundred sixteen HIV/HCV co-infected patients from nine hospitals in Spain were randomized to receive 270 microg/week of pegylated IFN… (More)

Topics

Cite this paper

@article{Tural2007SafetyAE, title={Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study.}, author={Cristina Tural and Ricard Sol{\'a} and Roser Rubio and M Santin and Ramon Planas and Carlos Quereda and Juan Berenguer and Mar{\'i}a Luisa Montes-Ram{\'i}rez and Bonaventura Clotet}, journal={Journal of viral hepatitis}, year={2007}, volume={14 10}, pages={704-13} }